Large B-cell lymphoma (LBCL) is one of the most aggressive lymphomas and accounts for about 30% of all lymphoma diagnoses.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
Research Immunotherapy lymphoma
Large B-cell lymphoma (LBCL) is one of the most aggressive lymphomas and accounts for about 30% of all lymphoma diagnoses.
A CU Cancer Center researcher recommended an experimental CAR T cell treatment to a Buena Vista wife and mother, who experienced great success with it.
Women with breast cancer commonly see their sexual health decline, yet their doctors aren't telling them what to expect -- or what to do about it.
Rare diseases, often called orphan diseases, are conditions that each affect fewer than 200,000 people in the United States. Living with one can be a nightmare. Symptoms can be life-altering and life-threatening.
A new study released by the University of Colorado Cancer Center shows that more than 70 percent of breast cancer patients have reported changes that affect their sexual health during and beyond treatment.
1665 North Aurora Court
2004
Aurora, CO 80045
720-848-0300
© 2022 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.